Susquehanna International Group
BIB icon

Susquehanna International Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Susquehanna International Group’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$660K Buy
8,100
+4,100
+103% +$340K ﹤0.01% 8945
2025
Q4 		$319K Sell
4,000
-1,400
-26% -$104K ﹤0.01% 9802
2025
Q3 		$322K Buy
+5,400
New +$291K ﹤0.01% 9949
2025
Q2 		– Sell
-4,300
Closed -$207K – 12664
2025
Q1 		$207K Sell
4,300
-2,800
-39% -$150K ﹤0.01% 10860
2024
Q4 		$360K Sell
7,100
-1,500
-17% -$88.9K ﹤0.01% 9422
2024
Q3 		$548K Sell
8,600
-1,700
-17% -$110K ﹤0.01% 8240
2024
Q2 		$610K Sell
10,300
-7,000
-40% -$387K ﹤0.01% 7784
2024
Q1 		$995K Sell
17,300
-7,200
-29% -$418K ﹤0.01% 6930
2023
Q4 		$1.4M Buy
24,500
+12,400
+102% +$581K ﹤0.01% 6163
2023
Q3 		$580K Sell
12,100
-13,400
-53% -$688K ﹤0.01% 7878
2023
Q2 		$1.33M Sell
25,500
-16,500
-39% -$909K ﹤0.01% 6041
2023
Q1 		$2.28M Buy
42,000
+10,600
+34% +$598K ﹤0.01% 4863
2022
Q4 		$1.81M Sell
31,400
-9,300
-23% -$524K ﹤0.01% 4895
2022
Q3 		$1.94M Buy
40,700
+13,600
+50% +$725K ﹤0.01% 4987
2022
Q2 		$1.31M Buy
27,100
+4,800
+22% +$244K ﹤0.01% 5871
2022
Q1 		$1.38M Sell
22,300
-35,300
-61% -$2.17M ﹤0.01% 6342
2021
Q4 		$4.67M Buy
57,600
+32,400
+129% +$2.78M ﹤0.01% 3858
2021
Q3 		$2.39M Sell
25,200
-33,800
-57% -$3.42M ﹤0.01% 5459
2021
Q2 		$5.81M Buy
59,000
+41,700
+241% +$3.64M ﹤0.01% 3755
2021
Q1 		$1.45M Buy
17,300
+2,700
+18% +$255K ﹤0.01% 6746
2020
Q4 		$1.26M Buy
14,600
+5,300
+57% +$410K ﹤0.01% 6146
2020
Q3 		$653K Sell
9,300
-8,800
-49% -$624K ﹤0.01% 7112
2020
Q2 		$1.31M Sell
18,100
-41,300
-70% -$2.64M ﹤0.01% 5311
2020
Q1 		$2.75M Buy
59,400
+16,500
+38% +$919K ﹤0.01% 3433
2019
Q4 		$2.65M Sell
42,900
-6,900
-14% -$368K ﹤0.01% 3888
2019
Q3 		$2.12M Sell
49,800
-20,100
-29% -$953K ﹤0.01% 4069
2019
Q2 		$3.62M Sell
69,900
-19,000
-21% -$945K ﹤0.01% 3165
2019
Q1 		$4.93M Buy
88,900
+73,700
+485% +$3.97M ﹤0.01% 2480
2018
Q4 		$640K Sell
15,200
-4,000
-21% -$209K ﹤0.01% 5549
2018
Q3 		$1.34M Sell
19,200
-58,000
-75% -$3.79M ﹤0.01% 4690
2018
Q2 		$4.42M Sell
77,200
-74,200
-49% -$4.05M ﹤0.01% 2876
2018
Q1 		$8.34M Buy
151,400
+38,200
+34% +$2.29M ﹤0.01% 1971
2017
Q4 		$6.35M Buy
113,200
+4,600
+4% +$259K ﹤0.01% 2272
2017
Q3 		$6.65M Sell
108,600
-137,000
-56% -$7.79M ﹤0.01% 2170
2017
Q2 		$13.1M Buy
245,600
+168,300
+218% +$8.21M 0.01% 1475
2017
Q1 		$3.73M Buy
77,300
+18,800
+32% +$874K ﹤0.01% 2702
2016
Q4 		$2.33M Sell
58,500
-172,600
-75% -$7.37M ﹤0.01% 3745
2016
Q3 		$11.2M Buy
231,100
+198,400
+607% +$9.43M 0.01% 1437
2016
Q2 		$1.27M Sell
32,700
-9,600
-23% -$414K ﹤0.01% 4373
2016
Q1 		$1.73M Sell
42,300
-57,300
-58% -$2.53M ﹤0.01% 4049
2015
Q4 		$7.12M Buy
99,600
+23,100
+30% +$1.54M ﹤0.01% 2104
2015
Q3 		$4.46M Sell
76,500
-74,500
-49% -$6.35M ﹤0.01% 2841
2015
Q2 		$13.6M Buy
151,000
+52,600
+53% +$4.53M 0.01% 1665
2015
Q1 		$7.79M Buy
98,400
+12,200
+14% +$905K ﹤0.01% 2153
2014
Q4 		$5.41M Sell
86,200
-38,600
-31% -$2.26M ﹤0.01% 2776
2014
Q3 		$6.49M Sell
124,800
-1,800
-1% -$87.2K ﹤0.01% 2654
2014
Q2 		$5.88M Buy
126,600
+17,200
+16% +$679K ﹤0.01% 2823
2014
Q1 		$4.37M Buy
+109,400
New +$4.97M ﹤0.01% 3073

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
KFS
Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Susquehanna International Group's BIB Position: Q1 2026 in Review

Susquehanna International Group increased its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 105% in Q1 2026, buying an estimated $561K and bringing the position to 13,212 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #7693.

Susquehanna International Group first reported a position in BIB in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.88M in Q3 2020. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2026.

  • Susquehanna International Group held 13,212 shares of ProShares Ultra NASDAQ Biotechnology worth $1.08M as of Q1 2026.
  • Susquehanna International Group bought 6,775 ProShares Ultra NASDAQ Biotechnology shares in Q1 2026, an estimated $561K.
  • ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7693 holding.
  • Susquehanna International Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and has held it in 44 quarters since.
  • Susquehanna International Group's ProShares Ultra NASDAQ Biotechnology position peaked at $3.88M in Q3 2020.
  • 23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.